BBH Holdings Information

BBH is an equity ETF with a total of 26 individual holdings. The top holdings are Gilead Sciences stock at 12.53%, Amgen at 12.39%, Vertex Pharmaceuticals at 9.51%, IQVIA Holdings at 5.02%, and argenx SE at 4.98%.

Total Holdings

Top 10 Percentage

67.06%

Asset Class

Equity

ETF Category

Health

Assets

350.77M

PE Ratio

20.37

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	GILD	Gilead Sciences, Inc.	12.53%	363,435
2	AMGN	Amgen Inc.	12.39%	149,049
3	VRTX	Vertex Pharmaceuticals Incorporated	9.51%	79,210
4	IQV	IQVIA Holdings Inc.	5.02%	79,837
5	ARGX	argenx SE	4.98%	21,382
6	REGN	Regeneron Pharmaceuticals, Inc.	4.83%	29,343
7	NTRA	Natera, Inc.	4.64%	84,621
8	ALNY	Alnylam Pharmaceuticals, Inc.	4.59%	34,753
9	INSM	Insmed Incorporated	4.58%	100,594
10	ONC	BeOne Medicines AG	3.99%	45,048
11	UTHR	United Therapeutics Corporation	3.33%	27,885
12	BIIB	Biogen Inc.	3.32%	77,837
13	ICLR	ICON Public Limited Company	3.21%	63,268
14	ILMN	Illumina, Inc.	2.48%	86,859
15	NBIX	Neurocrine Biosciences, Inc.	2.44%	59,448
16	BNTX	BioNTech SE	2.39%	79,387
17	INCY	Incyte Corporation	2.26%	86,952
18	TEM	Tempus AI, Inc.	1.98%	77,996
19	QGEN	Qiagen N.V.	1.86%	132,343
20	TECH	Bio-Techne Corporation	1.80%	95,905
21	MRNA	Moderna, Inc.	1.78%	233,220
22	EXAS	Exact Sciences Corporation	1.58%	85,918
23	CRL	Charles River Laboratories International, Inc.	1.56%	27,811
24	RGEN	Repligen Corporation	1.48%	31,318
25	BMRN	BioMarin Pharmaceutical Inc.	1.40%	90,427

Showing 25 of 26 holdings

Subscribe to see the full list

Upgrade Now

As of Oct 25, 2025